Metagame

Beyond xAI the 2 billion semiconductor bet nobody covered

While everyone obsessed over OpenAI's $122 billion raise, $4.3 billion quietly flowed through SEC filings into eight companies nobody talked about—inference chips, data infrastructure, AI hiring platforms—the actual plumbing that makes frontier AI work. Marvell raised $2 billion for custom silicon, MatX got $530 million for inference optimization, and Mercor landed $330 million targeting the skills gap that's killing 95% of enterprise AI pilots. The mega-rounds got the headlines but the SEC Form D tape just showed you what smart money is actually buying: the companies OpenAI can't operate without.

Pharma deal flow collapsed 62 percent while AI startups hide in plain sight

Pharma deal flow didn't collapse 62.5 percent last quarter — it just stopped filing as pharma. AI-native drug discovery companies like Recursion and Insitro are filing under "Other Technology" because their value lives in computational platforms, not clinical pipelines, which means healthcare funds tracking SEC codes are literally missing deals before they hit the committee. Total healthcare-adjacent deal count stayed completely flat at 74 deals, but if your allocation strategy runs on sector labels instead of manual tagging, you're benchmarking against a category that no longer describes where the actual capital is flowing.

New York venture deals now outpace entire Bay Area combined

NYC just closed 119 venture deals worth $70.4 billion in Q1 while San Francisco proper did 39 deals at $4.7 billion, and somehow the entire VC world is still pretending you have to be in the Bay to access deals. The gap isn't even close—New York has a 65% deal-count advantage, and here's the kicker: Atlanta matched San Francisco at 39 deals each. Everyone's optimizing for geographic proximity to AI labs while SEC Form D data shows the actual repeatable deal velocity is happening 3,000 miles east, but nobody's updated the conference talking points yet.

Where 59 billion in new startup capital actually went this quarter

That $300 billion Q1 venture number everyone freaked out about? Strip out four mega-deals – OpenAI, Anthropic, xAI, Waymo – and the real market was 586 companies raising a median of $22.9 million, running 13 deals per business day while you were staring at the wrong scoreboard. Horizontal SaaS just got crushed with 35% down multiples while vertical software held strong, and now OpenAI and Anthropic are literally trying to buy implementation firms because the bottleneck moved from AI models to actually deploying them inside companies.

xAI captured 57 percent of US other technology venture funding in Q1

One company just raised $16.6 billion and accidentally became 57% of an entire tech sector category tracked by the SEC. Strip out xAI's single filing and "Other Technology" doesn't just shrink — it collapses from $29 billion to $12.5 billion, and the average deal size drops from $164 million to $71 million. If you're building investment models or AI benchmarks off those aggregate numbers, you're not tracking a market — you're tracking one Palo Alto address with a spreadsheet wrapped around it.